These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30714573)

  • 1. The role of magnesium and zinc in depression: similarities and differences.
    Szewczyk B; Szopa A; Serefko A; Poleszak E; Nowak G
    Magnes Res; 2018 Aug; 31(3):78-89. PubMed ID: 30714573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials.
    Lai J; Moxey A; Nowak G; Vashum K; Bailey K; McEvoy M
    J Affect Disord; 2012 Jan; 136(1-2):e31-e39. PubMed ID: 21798601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc and depression. An update.
    Nowak G; Szewczyk B; Pilc A
    Pharmacol Rep; 2005; 57(6):713-8. PubMed ID: 16382189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action.
    Szewczyk B; Poleszak E; Sowa-Kućma M; Siwek M; Dudek D; Ryszewska-Pokraśniewicz B; Radziwoń-Zaleska M; Opoka W; Czekaj J; Pilc A; Nowak G
    Pharmacol Rep; 2008; 60(5):588-9. PubMed ID: 19066406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB
    Wośko S; Serefko A; Szopa A; Wlaź P; Wróbel A; Wlaź A; Górska J; Poleszak E
    J Pharm Pharmacol; 2018 Apr; 70(4):566-575. PubMed ID: 29380383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action.
    Nowak G
    Pharmacol Rep; 2015 Jun; 67(3):659-62. PubMed ID: 25933983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial.
    Barragán-Rodríguez L; Rodríguez-Morán M; Guerrero-Romero F
    Magnes Res; 2008 Dec; 21(4):218-23. PubMed ID: 19271419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of zinc in the development and treatment of mood disorders.
    Cope EC; Levenson CW
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):685-9. PubMed ID: 20689416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of zinc with antidepressants in the forced swimming test in mice.
    Szewczyk B; Brański P; Wierońska JM; Pałucha A; Pilc A; Nowak G
    Pol J Pharmacol; 2002; 54(6):681-5. PubMed ID: 12866724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential elements in depression and anxiety. Part I.
    Młyniec K; Davies CL; de Agüero Sánchez IG; Pytka K; Budziszewska B; Nowak G
    Pharmacol Rep; 2014 Aug; 66(4):534-44. PubMed ID: 24948052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine and magnesium common pathway of antidepressant action.
    Górska N; Cubała WJ; Słupski J; Gałuszko-Węgielnik M
    Magnes Res; 2018 May; 31(2):33-38. PubMed ID: 30398153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
    Nowak G; Siwek M; Dudek D; Zieba A; Pilc A
    Pol J Pharmacol; 2003; 55(6):1143-7. PubMed ID: 14730113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP).
    Nagler EV; Webster AC; Vanholder R; Zoccali C
    Nephrol Dial Transplant; 2012 Oct; 27(10):3736-45. PubMed ID: 22859791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant pharmacotherapy in old-age depression-a review and clinical approach.
    Pruckner N; Holthoff-Detto V
    Eur J Clin Pharmacol; 2017 Jun; 73(6):661-667. PubMed ID: 28280892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.
    Karamali M; Bahramimoghadam S; Sharifzadeh F; Asemi Z
    Appl Physiol Nutr Metab; 2018 Jun; 43(6):565-570. PubMed ID: 29316405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological treatment of resistant depression].
    Bertera HJ
    Vertex; 2005; 16(64):460-8. PubMed ID: 16314901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms contributing to antidepressant zinc actions.
    Nowak G; Szewczyk B
    Pol J Pharmacol; 2002; 54(6):587-92. PubMed ID: 12866713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium and depression.
    Serefko A; Szopa A; Poleszak E
    Magnes Res; 2016 Mar; 29(3):112-119. PubMed ID: 27910808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence.
    Hoepner CT; McIntyre RS; Papakostas GI
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.